Results
1 -
10 of
15
(Click
here to explore results)
- Successful Strategies for the Discovery of Antiviral Drugs, CHAPTER 7 HCV NS3/4a Protease Inhibitors: Simeprevir (TMC‐435350), Vaniprevir (MK‐7009) and MK‐5172. John A. McCauley, Michael T. Rudd, Nigel J. Liverton
, 2013
, Pages 189-247
- Macrocycles in Drug Discovery, CHAPTER 7 Linear and Macrocyclic Hepatitis C Virus Protease Inhibitors: Inhibitor Design and Macrocyclization Strategies for HCV Protease and Related Targets. Wieslaw M. Kazmierski, Richard L. Jarvest, Jacob J. Plattner, Xianfeng Li
, 2015
, Pages 235-282
- Successful Strategies for the Discovery of Antiviral Drugs, Subject index
, 2013
, Pages 509-534
- The Coronavirus Pandemic and the Future: Virology, Epidemiology, Translational Toxicology and Therapeutics, Volume 2, CHAPTER 1 In Silico Approaches for Drug Repurposing for SARS-CoV-2 Infection. Sudhir A. Kulkarni, Kundan Ingale
, 2022
, Volume 2
, Pages 1-80
- Macrocycles in Drug Discovery, CHAPTER 11 The Synthesis of Macrocycles for Drug Discovery. Mark L. Peterson
, 2015
, Pages 398-486
- Antiviral Discovery for Highly Pathogenic Emerging Viruses, Chapter 1 Overview of Antiviral Drug Discovery and Development: Viral Versus Host Targets. Guangdi Li, Erik De Clercq
, 2022
, Pages 1-27
- Macrocycles in Drug Discovery, Subject Index
, 2015
, Pages 487-499
- Successful Strategies for the Discovery of Antiviral Drugs, Contents
, 2013
, Pages P009-P016
- Macrocycles in Drug Discovery, Contents
, 2015
, Pages P013-P020
- Peptide Therapeutics: Strategy and Tactics for Chemistry, Manufacturing, and Controls, Chapter 12 Transport, Stability and Delivery Considerations for the Design of Peptide Drugs. Tomi Sawyer, Jerome Hochman, Suzanne M. D'Addio, Brad Sherborne, Marian E. Gindy
, 2019
, Pages 421-471